Doutor Nichires Holdings Co., Ltd.

Doutor Nichires Holdings Co., Ltd.

3,540.00
JPY
+10.00
(+0.28%)
139.58EPS
15.96P/E
96.98BMarket Cap
Jan 08Next Earn
Doutor Nichires Holdings Co., Ltd.
TSE:3087
(Tokyo Stock Exchange)

Recent

price

3,540.00

P/E

ratio

15.96

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
2,096.32
2,199.47
2,237.45
2,355.68
2,490.56
2,589.67
2,658.16
2,807.35
2,924.56
2,969.38
2,174.94
2,474.77
2,869.03
3,198.07
339.5
3,755.59
3,307.07
Revenue per Share
80.23
51.31
74.66
80.43
108.3
113.22
126.7
142.81
133.88
137.11
-248.37
27.63
77.55
124.88
15.7
170.71
138.58
Basic EPS, GAAP
139.14
91.98
113.01
107.14
48.27
69.54
94.2
90.91
106.92
172.36
-182.4
231.25
-5
156.26
14.7
43.16
- -
Free Cash Flow per Basic Share
26.11
25.99
26.06
26
27.02
27.99
29.03
31.5
31.98
33
28.71
24.26
27.97
35.91
4.3
54.65
- -
Dividend per Share
1,656.16
1,698.72
1,770.01
1,827.84
1,916.29
1,987.07
2,092.31
2,191.72
2,295.66
2,397.92
2,121.03
2,122.63
2,171.3
2,262.84
2,372.09
2,502.91
2,336.3
Book Value per Share
1,621.01
1,664.63
1,740.84
1,809.62
1,897.3
1,962.77
2,066.53
2,162.71
2,273.98
2,379.07
2,106.91
2,109.63
2,154.09
2,239.75
2,354.05
2,487.53
2,315.59
Tangible Book Value per Share
50
49
48
48
48
48
48
47
44
44
44
44
44
44
438
42
44
Basic Weighted Avg Shares
105,011
107,721
107,825
113,520
120,020
124,796
126,927
131,182
129,216
131,193
96,141
109,363
126,864
140,625
148,822
159,147
144,927
Sales/Revenue/Turnover
25.27
6.59
6.66
7.45
8
7.59
8.29
7.88
7.85
7.84
-4.49
-1.63
2.34
5.21
6.45
6.38
6.21
Operating Margin (%)
3,777
3,817
3,633
3,680
3,773
4,072
4,336
4,287
4,464
4,687
4,517
4,184
3,913
4,257
4,604
4,665
- -
Depreciation Expense
4,019
2,513
3,598
3,876
5,219
5,456
6,050
6,673
5,915
6,058
-10,979
1,221
3,429
5,491
6,880
7,234
6,073
Net Income, GAAP
46.13
55.71
44.39
46.31
42.92
41.62
38.25
33.46
36.5
36.36
- -
63.24
13.96
25.65
25.64
26.8
29.17
Effective Tax Rate (%)
3.83
2.33
3.34
3.41
4.35
4.37
4.77
5.09
4.58
4.62
-11.42
1.12
2.7
3.9
4.62
4.55
4.19
Profit Margin (%)
13,265
17,097
27,204
27,916
29,497
33,586
34,318
30,810
31,758
36,811
29,905
32,771
32,926
35,054
37,708
33,356
37,762
Working Capital
895
745
704
799
964
1,381
1,345
1,024
684
819
841
1,009
1,178
1,832
1,516
1,530
1,727
LT Debt
81,370
81,940
85,379
88,201
92,431
95,833
99,460
96,956
101,581
106,138
93,999
94,108
96,291
99,472
104,350
105,553
102,763
Total Equity
4.79
3.62
4.53
4.97
5.79
5.62
6.37
6.73
6.26
6.11
- -
-0.68
2.6
5.38
6.72
6.78
6.09
Return on Invested Capital (%)
4.74
2.97
4.21
4.37
5.7
5.71
6.03
6.66
5.85
5.73
- -
1.24
3.52
5.46
6.59
6.74
5.89
Return on Capital (%)
4.98
3.08
4.3
4.47
5.79
5.8
6.2
6.8
5.97
5.84
-10.99
1.3
3.61
5.63
6.77
6.92
6.05
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Feb'24
May'25
Aug'25
ST Debt
563
596
596
LT Borrowings
139
177
148
LT Finance Leases
1,693
1,713
1,579
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
44
44
44
Market Capitalization
90,266
94,428
96,983

Working Capital

JPY

•

in mil. unless spec.
Feb'24
May'25
Aug'25
Total Current Assets
54,464
57,322
59,433
Cash, Cash Equivalents & STI
35,796
35,810
36,822
Accounts Receivable, Net
6,326
7,579
8,829
Inventories
5,226
5,463
5,590
Total Current Liabilities
19,410
20,762
21,671
Payables & Accruals
- -
- -
- -
ST Debt
563
596
596
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.09%
2.36%
1.15%
Free Cash Flow
-372.06%
-723.16%
-71.61%
Net Income, GAAP
-10.87%
32.06%
5.15%
Sales/Revenue/Turnover
3.17%
10.67%
6.94%
Total Cash Common Dividend
6.49%
13.95%
22.8%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
36,906
38,357
- -
- -
148,822
2026
- -
- -
- -
- -
159,147
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
54.29
41.93
- -
- -
15.7
2026
- -
- -
- -
- -
170.71
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
4.3
2026
- -
- -
- -
- -
54.65
2027
- -
- -
- -
- -
- -
Business
DOUTOR NICHIRES Holdings Co., Ltd. (3087.T) operates as a Japan-based holding company primarily engaged in the roasting, processing, and sale of coffee, as well as the operation and management of coffee shops, restaurants, and related food service businesses. The company offers a diverse portfolio of products and services through its two main segments: the Doutor Cafe Group, which manages coffee chains via directly managed stores and franchise systems, including the procurement, roasting, processing, and sale of coffee beans; and the Japan Restaurant System Group, which oversees restaurant chains, bakery production and sales including breads, pastries, confectionery products, hams, sausages, bacons, sauces, dressings, and foodstuffs such as fruits, vegetables, and meats. Additional operations encompass the manufacture and wholesale of coffee machines, import and export of food items, store design, construction, maintenance, cleaning services, and natural food stores, primarily targeting consumers in Japan under various brands specializing in Italian coffee and sandwiches, pasta, American food, Hawaiian coffee, Asian noodles, barbecue, donuts via the Nichires chain, candy, cheesecake, egg products, tea, and health foods. Founded in 2007 through the establishment of a joint holding company and headquartered at 10-11 Sarugaku-cho, Shibuya-ku, Tokyo, Japan, the company traces its origins to Doutor Coffee established in 1962 and has grown via strategic acquisitions and organic expansion into a diversified food and beverage entity with approximately 2,767 employees and nearly two dozen subsidiaries managing franchise chains. Recent developments include ongoing treasury share repurchases, with notices issued in July 2025 regarding status and completion, alongside multiple executions in June, May, and earlier periods; director changes announced in April 2025 and May 2025 for group companies; and restricted stock compensation disposals in May 2025. The company released its fiscal year 2025 financial results in April 2025, reporting revenue growth to approximately 151 billion yen, alongside interim and quarterly supplements through November 2025 demonstrating sustained segment performance in Doutor Coffee (89.1 billion yen) and Japanese Restaurant System (55.29 billion yen), with dividend adjustments upward in multiple periods including July 2025.